Clinicopathological profile of clear cell renal cell carcinoma


  • Pamela Kusumadewi Putri Thaib Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia | Universitas Airlangga Academic Hospital, Surabaya, Indonesia | Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
  • Anny Setijo Rahaju Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia | Universitas Airlangga Academic Hospital, Surabaya, Indonesia | Dr. Soetomo General Academic Hospital, Surabaya, Indonesia


carcinoma, clinicopathological, grade, incidence, kidney cancer


Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer with aggressive behavior. Tumor stage and grade are important parameter in diagnosis. Data about the clinical and pathology profile of ccRCC in Indonesia is limited, therefore further information is needed. The study aimed to determine clinicopathologic profile of ccRCC in Soetomo Academic General Hospital (SAGH). This descriptive study was conducted retrospectively with cross-sectional approach. Clinical and histopathological archives of ccRCC specimen were retrieved during January 2016 to December 2020. The total number of ccRCC cases obtained was 38 cases, the most cases (11) occurred in 2016. The average of patient’s age was 55.64 years. Patients were predominantly male (71.1%), with a ratio to female 2.5:1. The tumors mostly filled the entire kidney, in 15 (39.5%) cases. Most pT stage distribution was pT2, in 15 (39.5%) cases. Most N stage distribution was N0, in 23 (60.5%) cases. Only 5 (13.2%) cases showed multiple pulmonary nodules which suspected to be metastatic (M1). The most common tumors grade was G4, in 17 (44.7%) cases. In conclusion, ccRCC patient were predominantly male, tumors mostly high grade, filled entire kidney, not penetrated renal capsule, and not metastasize to regional lymph nodes.


Download data is not yet available.


Arimbawa, . I. M., Paramita, A. D. P., Nuaba, I. G. A., & Saputra, H. (2021). Management of hypocalcemia after modified bilateral radical neck dissection followed with total thyroidectomy: a case report. International Journal of Health Sciences, 5(1), 9-19.

Bergström, A., Hsieh, C. C., Lindblad, P., Lu, C. M., Cook, N. R., & Wolk, A. (2001). Obesity and renal cell cancer–a quantitative review. British journal of cancer, 85(7), 984-990.

Blom, J. H., van Poppel, H., Maréchal, J. M., Jacqmin, D., Schröder, F. H., de Prijck, L., & Sylvester, R. (2009). Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. European urology, 55(1), 28-34.

Brugarolas, J. (2014). Molecular genetics of clear-cell renal cell carcinoma. Journal of clinical oncology, 32(18), 1968.

Buckner, J. C. (2003, December). Factors influencing survival in high-grade gliomas. In Seminars in oncology (Vol. 30, pp. 10-14). WB Saunders.

Campbell, S. C., & Rini, B. I. (2009). Renal cell carcinoma. People's Medical Publishing House USA Limited (PMPH).

Cancer Genome Atlas Research Network. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43.

Chen, D., Gassenmaier, M., Maruschke, M., Riesenberg, R., Pohla, H., Stief, C. G., ... & Buchner, A. (2014). Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma. The Journal of urology, 191(2), 479-486.

de Peralta-Venturina, M., Moch, H., Amin, M., Tamboli, P., Hailemariam, S., Mihatsch, M., ... & Amin, M. B. (2001). Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. The American journal of surgical pathology, 25(3), 275-284.

Dharmayuda, T. G., Suega, K., Bakta, I. M., & Sumohadi, I. M. D. (2021). Ki67 expression and prognostic aspects of colorectal cancer. International Journal of Health Sciences, 5(2), 79-88.

Dispagna, M. A., Daneshvar, M., & Bratslavsky, G. (2021). Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma. International braz j urol, 47, 935-942.

Erdo?an, F., Demirel, A., & Polat, Ö. (2004). Prognostic significance of morphologic parameters in renal cell carcinoma. International journal of clinical practice, 58(4), 333-336.

Evans, A. J., Russell, R. C., Roche, O., Burry, T. N., Fish, J. E., Chow, V. W., ... & Ohh, M. (2007). VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Molecular and cellular biology, 27(1), 157-169.

Ferlay, J. S. E. M., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., ... & Bray, F. (2013). GLOBOCAN 2012 v1. 0. Cancer incidence and mortality worldwide: IARC CancerBase, 11.

Fowkes, F. J. I., Price, J. F., & Fowkes, F. G. R. (2003). Incidence of diagnosed deep vein thrombosis in the general population: systematic review. European Journal of Vascular and Endovascular Surgery, 25(1), 1-5.

Gershman, B., Thompson, R. H., Moreira, D. M., Boorjian, S. A., Lohse, C. M., Costello, B. A., ... & Leibovich, B. C. (2017). Lymph node dissection is not associated with improved survival among patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma: a propensity score based analysis. The Journal of urology, 197(3), 574-579.

Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011). GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of clinical epidemiology, 64(4), 380-382.

Hakimi, A. A., Reznik, E., Lee, C. H., Creighton, C. J., Brannon, A. R., Luna, A., ... & Hsieh, J. J. (2016). An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer cell, 29(1), 104-116.

Hamid, A. R. A. H., Umbas, R., Oka, A. A. G., Mochtar, C. A., Djatisoesanto, W., Soedarso, M. A., ... & Hakim, L. (2019). KANKER GINJAL.

He, H., & Magi-Galluzzi, C. (2014). Epithelial-to-mesenchymal transition in renal neoplasms. Advances in anatomic pathology, 21(3), 174-180.

HsiehJJ, P., SignorettiS, S., AlbigesL, S., & HengDY, L. (2017). FicarraV.. Renal cell carcinoma. Nat Rev Dis Primers, 3, 17009.

Hu, T. H., Yao, Y., Yu, S., Han, L. L., Wang, W. J., Guo, H., ... & Nan, K. J. (2014). SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/?-catenin signaling pathway. Cancer letters, 354(2), 417-426.

Irwin, D. J. (2016). Tauopathies as clinicopathological entities. Parkinsonism & related disorders, 22, S29-S33.

Jayson, M., & Sanders, H. (1998). Increased incidence of serendipitously discovered renal cell carcinoma. Urology, 51(2), 203-205.

Jewett, M. A., Mattar, K., Basiuk, J., Morash, C. G., Pautler, S. E., Siemens, D. R., ... & Finelli, A. (2011). Active surveillance of small renal masses: progression patterns of early stage kidney cancer. European urology, 60(1), 39-44.

Jiang, J., Tang, Y. L., & Liang, X. H. (2011). EMT: a new vision of hypoxia promoting cancer progression. Cancer biology & therapy, 11(8), 714-723.

Kaelin Jr, W. G. (2007). Von hippel-lindau disease. Annu. Rev. Pathol. Mech. Dis., 2, 145-173.

Kim, S. J., Hong, Y. P., Lew, W. J., Yang, S. C., & Lee, E. G. (1995). Incidence of pulmonary tuberculosis among diabetics. Tubercle and lung disease, 76(6), 529-533.

Klatte, T., Rao, P. N., De Martino, M., LaRochelle, J., Shuch, B., Zomorodian, N., ... & Pantuck, A. J. (2009). Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. Journal of clinical oncology, 27(5), 746-753.

Klatte, T., Rossi, S. H., & Stewart, G. D. (2018). Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World journal of urology, 36(12), 1943-1952.

Kurban, G., Hudon, V., Duplan, E., Ohh, M., & Pause, A. (2006). Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer research, 66(3), 1313-1319.

Landolt, L., Eikrem, Ø., Strauss, P., Scherer, A., Lovett, D. H., Beisland, C., ... & Marti, H. P. (2017). Clear cell renal cell carcinoma is linked to epithelial?to?mesenchymal transition and to fibrosis. Physiological reports, 5(11), e13305.

Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003). von Hippel-Lindau disease. The Lancet, 361(9374), 2059-2067.

Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010). Hypoxia-inducible factors and the response to hypoxic stress. Molecular cell, 40(2), 294-309.

Mikami, S., Katsube, K. I., Oya, M., Ishida, M., Kosaka, T., Mizuno, R., ... & Okada, Y. (2011). Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Laboratory investigation, 91(10), 1443-1458.

Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E., & Ulbright, T. M. (2016). The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. European urology, 70(1), 93-105.

Octavianda, Y., & Rahaju, A. S. (2018). Increased HIF-1alpha And VEGF Expression Found in Various T Stages of Clear Cell Renal Cell Carcinoma. Folia Medica Indonesiana, 54(2), 102-107.

Padala, S. A., Barsouk, A., Thandra, K. C., Saginala, K., Mohammed, A., Vakiti, A., ... & Barsouk, A. (2020). Epidemiology of renal cell carcinoma. World journal of oncology, 11(3), 79.

Rini, R. (2017). Fake news and partisan epistemology. Kennedy Institute of Ethics Journal, 27(2), E-43.

Sagalowsky, A. I., Kadesky, K. T., Ewalt, D. M., & Kennedy, T. J. (1994). Factors influencing adrenal metastasis in renal cell carcinoma. The Journal of urology, 151(5), 1181-1184.

Sandock, D. S., Seftel, A. D., & Resnick, M. I. (1997). Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage. Urology, 49(1), 28-31.

Surgical Pathology Clinics, 11(4), pp.797-812. DOI: 10.1016/j.path.2018.07.004

Taneja, K., & Williamson, S. R. (2018). Updates in pathologic staging and histologic grading of renal cell carcinoma. Surgical pathology clinics, 11(4), 797-812.

Vogelzang, N. J., & Stadler, W. M. (1998). Kidney cancer. The Lancet, 352(9141), 1691-1696.

Wang, C. A., & Gaz, R. D. (1985). Natural history of parathyroid carcinoma: diagnosis, treatment, and results. The American journal of surgery, 149(4), 522-527.

Williams, D. R., & Lees, A. J. (2009). Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. The Lancet Neurology, 8(3), 270-279.

Zagzag, D., Krishnamachary, B., Yee, H., Okuyama, H., Chiriboga, L., Ali, M. A., ... & Semenza, G. L. (2005). Stromal cell–derived factor-1? and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer research, 65(14), 6178-6188.



How to Cite

Thaib, P. K. P., & Rahaju, A. S. (2022). Clinicopathological profile of clear cell renal cell carcinoma. International Journal of Health & Medical Sciences, 5(1), 91-100.



Peer Review Articles